(Total Views: 437)
Posted On: 09/24/2021 10:01:42 AM
Post# of 155189
What has the "investor group" said about Cancer before. Let's look at their September 2 letter (not the PR, but the letter) that is on their website:
Doesn't sound like the "investor group" is going out of their way to help the cancer approval process, does it? Now, as we approach the election date, they are on board with cancer. Please.....
Quote:
•July 19, 2021:
o Announcement: CYDY announced that its clinical trial with Leronlimab in combination with carboplatin for the treatment of metastatic breast cancer advanced from Phase 1b to a Phase 2 trial and received strong results in both trials.
o Facts: While CYDY went out of its way to make the results of the trial sound impressive, their scientific legitimacy is questionable at best. This was an open label trial with no masking, patients were not randomly assigned, and there was no control group involved. As such, the Company inappropriately compared the results to statistics of survival for a general population of metastatic breast cancer patients. Without an actual clinical trial showing statistical significance, further progress will be difficult to obtain.
o Stock Price: The stock price dropped almost 5% in the seven trading days following the announcement.
Doesn't sound like the "investor group" is going out of their way to help the cancer approval process, does it? Now, as we approach the election date, they are on board with cancer. Please.....
(12)
(1)
